High ThroughputPARP in vivo Pharmacodynamic Assay|
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.
AstraZeneca Licenses Labguru Research and Lab Management Software
Thursday, February 19, 2015
Technology solution to streamline collaborations between lab staff and across institutions.
Cellular Dynamics’ iCell Hepatocytes Enable Malaria-in-a-Dish Studies
Thursday, February 12, 2015
Study published in February issue of Stem Cell Reports describes successful use of iPSC-derived cells for development of anti-malarial drug testing.
CAP® Derived Recombinant C1 Inhibitor Matches Berinert® in Animal Study
Tuesday, February 03, 2015
A safer and more economic therapy for acute and prophylactic HAE indications.
Hepregen Launches First Dog HepatoPac® Assay Kit
Friday, January 30, 2015
Application-directed kit complements human, rat and monkey counterparts.